Katsuno Hidetoshi, Zacharakis Emmanouil, Aziz Omer, Rao Christopher, Deeba Samer, Paraskeva Paraskeva, Ziprin Paul, Athanasiou Thanos, Darzi Ara
Department of Biosurgery and Surgical Technology, Imperial College London, St Mary's Hospital, 10th Floor, QEQM Wing, St Mary's Campus, Praed Street, London W2 1NY, UK.
Ann Surg Oncol. 2008 Nov;15(11):3083-91. doi: 10.1245/s10434-008-0131-8. Epub 2008 Sep 12.
Hepatic metastasis can occur following curative colorectal cancer surgery despite favorable prognostic indicators, raising the question of whether detecting circulating tumor cells in the venous drainage of colorectal cancers at resection using reverse-transcriptase polymerase chain reaction would help determine prognosis. This study compares lymph node positivity, hepatic metastasis rates, and disease-free survival in circulating tumor positive versus negative patients.
A Medline, Embase, Ovid, and Cochrane database search was conducted on all studies between 1999 and 2006 reporting the outcomes of interest. Meta-analysis was performed in line with recommendations from the Cochrane Collaboration and the Quality of Reporting of Meta-Analyses guidelines.
Nine studies reporting on 646 subjects published between 1998 and 2006 matched the selection criteria and were suitable for inclusion in this meta-analysis. There was a significantly higher incidence of circulating tumor cells (50%) in lymph node positive compared with negative groups (21%) [odds ratio (OR) = 3.83, confidence interval (CI) = 2.46-5.94], and a significantly increased hepatic metastases rate (21%) in circulating tumor cells positive compared with in negative patients (8%, OR = 6.38; CI = 2.67-15.25. Disease-free survival was significantly higher in the circulating tumor cell negative versus positive groups at 1 year [hazard ratio (HR) = 0.04, CI = 0-0.46], 2 years (HR = 0.05, CI = 0.01-0.31), and 3 years (HR = 0.08, CI = 0.02-0.34) post resection.
This study highlights the potential importance of free cancer cell detection in the venous drainage of colorectal cancers as a prognostic indicator and a mode of staging colorectal cancers.
尽管有良好的预后指标,但在结直肠癌根治性手术后仍可能发生肝转移,这就提出了一个问题,即使用逆转录酶聚合酶链反应在切除时检测结直肠癌静脉引流中的循环肿瘤细胞是否有助于判断预后。本研究比较了循环肿瘤细胞阳性和阴性患者的淋巴结阳性率、肝转移率和无病生存率。
对1999年至2006年间所有报告感兴趣结果的研究进行了Medline、Embase、Ovid和Cochrane数据库检索。根据Cochrane协作网的建议和Meta分析报告质量指南进行Meta分析。
1998年至2006年间发表的9项报告646名受试者的研究符合选择标准,适合纳入本Meta分析。与阴性组(21%)相比,淋巴结阳性组循环肿瘤细胞的发生率显著更高(50%)[比值比(OR)=3.83,置信区间(CI)=2.46-5.94],与循环肿瘤细胞阴性患者(8%,OR=6.38;CI=2.67-15.25)相比,循环肿瘤细胞阳性患者的肝转移率显著增加。切除术后1年[风险比(HR)=0.04,CI=0-0.46]、2年(HR=0.05,CI=0.01-0.31)和3年(HR=